LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Mike Bonney, Cubist’s CEO, will present at the Morgan Stanley Global Healthcare Conference on Monday, September 9, to discuss the company’s business activities, financial outlook, and current news.
The presentation will be held at the Grand Hyatt New York hotel in New York City on Monday, September 9, 2013 at 3:50 p.m. Eastern Time.
This audio-only presentation will be accessible live through Cubist’s website at www.cubist.com in the Investor Relations Conference Calendar section and will remain available there for a period of 30 days after the presentations.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s website.